- Project
- CAS No.
- Indications
- Remark
- Iptacopan
- 1644670-37-0
- High‑selectivity complement factor B inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and C3 glomerulopathy (C3G)
- process scale‑up
- Danicopan
- 1903768-17-1
- Small-molecule complement factor D inhibitor, for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)
- process scale‑up
- Oclacitinib
- 1208319-26-9
- Novel JAK inhibitor for the control of pruritus caused by canine allergic dermatitis and atopic dermatitis
- process scale‑up
- Ensifentrine
- 1884461-72-6
- A novel, inhaled, long‑acting, selective phosphodiesterase 3 and 4 (PDE3/4) inhibitor for the treatment of respiratory diseases including chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Revefenacin
- 864750-70-9
- A long‑acting muscarinic antagonist for the maintenance treatment of chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Salbutamol
- 18559-94-9
- Short‑acting β2‑adrenergic receptor agonist for the relief of asthma or chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Olodaterol hydrochloride
- 869477-96-3
- Long‑acting β2‑adrenergic receptor agonist (LABA) for the long‑term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Vilanterol Trifenatate
- 503070-58-4
- Long‑acting β2‑adrenergic receptor agonist for the maintenance treatment of adult patients with chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Umeclidinium bromide
- 869113-09-7
- Long‑acting muscarinic receptor antagonist for the treatment of chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Indacaterol acetate
- 1000160-96-2
- Long‑acting β2‑adrenergic agonist for the long‑term maintenance treatment of chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Formoterol fumarate
- 43229-80-7
- β₂drenergic receptor agonist for the treatment of chronic obstructive pulmonary disease (COPD)
- process scale‑up
- Ipratropium Bromide
- 22254-24-6
- A short‑acting anticholinergic agent for relieving symptoms such as dyspnea caused by bronchospasm
- process scale‑up
- Vemakalant
- 794466-70-9
- Anti‑arrhythmic agent for rapid cardioversion of recent‑onset atrial fibrillation in adults
- process scale‑up
- Venetoclax
- 1257044-40-8
- Indicated for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and acute myeloid leukemia (AML)
- process scale‑up
- Vemurafenib
- 918504-65-1
- For the treatment of unresectable or metastatic melanoma with BRAF V600 mutation‑positive status as determined by a CFDA‑approved assay.
- process scale‑up
